The global bioengineered protein drugs market was valued at US$ 347.1 Bn in 2023 and is projected to expand at a CAGR of 6.2% from 2024 to 2034, reaching approximately US$ 672.7 Bn by the end of 2034. Increasing prevalence of chronic diseases, growing adoption of advanced biopharmaceutical technologies, and substantial investments in drug discovery and development are creating a favorable...